These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21142623)

  • 1. Risk factors for mortality and impact of broad-spectrum cephalosporin resistance on outcome in bacteraemic intra-abdominal infections caused by Gram-negative bacilli.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Scand J Infect Dis; 2011 Mar; 43(3):202-8. PubMed ID: 21142623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
    J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
    Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
    Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial comment.
    Solomkin JS
    Scand J Infect Dis; 2011 Mar; 43(3):163-4. PubMed ID: 21319939
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug resistant gram-negative bacilli as predominant bacteremic pathogens in liver transplant recipients.
    Shi SH; Kong HS; Xu J; Zhang WJ; Jia CK; Wang WL; Shen Y; Zhang M; Zheng SS
    Transpl Infect Dis; 2009 Oct; 11(5):405-12. PubMed ID: 19638006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
    Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
    J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
    Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
    J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
    Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
    Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
    Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
    Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
    Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
    Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rising influx of multidrug-resistant gram-negative bacilli into a tertiary care hospital.
    Pop-Vicas AE; D'Agata EM
    Clin Infect Dis; 2005 Jun; 40(12):1792-8. PubMed ID: 15909268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality in bloodstream infections caused by multidrug-resistant gram-negative bacteria: 4 years of collection.
    Wang W; Jiang T; Zhang W; Li C; Chen J; Xiang D; Cao K; Qi LW; Li P; Zhu W; Chen W; Chen Y
    Am J Infect Control; 2017 Jan; 45(1):59-64. PubMed ID: 27765296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
    Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
    J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
    Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
    J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.